{"brief_title": "Efficacy and Safety of LY451395 in Patients With Probable Alzheimer's Disease", "brief_summary": "Study of an investigational medication for the treatment of Alzheimer's Disease in patients who are not taking Aricept, Reminyl, Exelon.", "condition": "Alzheimer's Disease", "intervention_type": "Drug", "intervention_name": "LY451395", "criteria": "Inclusion Criteria: - Must have a clinical diagnosis of Alzheimer's Disease - Must be at least 50 years of age - Must fluently read and speak English - Must have a reliable caregiver Exclusion Criteria: - Has serious health problems other than Alzheimer's Disease - Cannot swallow whole pills - Has had a menstrual period in the last two years - Takes insulin for diabetes - Has taken Aricept, Reminyl, or Exelon in the last 5 weeks", "gender": "All", "minimum_age": "50 Years", "maximum_age": "N/A", "healthy_volunteers": "Accepts Healthy Volunteers", "id": "NCT00051909.xml"}